Jenscare Scientific Co., Ltd. (JENSCARE-B, 09877) has announced that its board of directors will convene on Thursday, 26 March 2026. The session’s agenda includes:
• Reviewing and approving the consolidated financial results for the year ended 31 December 2025. • Considering a recommendation for the payment of a final dividend, if any. • Addressing other routine corporate matters.
The notice was issued by Executive Director and Chief Executive Officer Mr. Pan Fei on 16 March 2026. As of the announcement date, the board comprises one executive director, five non-executive directors and three independent non-executive directors.